Free Trial
NASDAQ:CSCI

COSCIENS Biopharma (CSCI) Stock Price, News & Analysis

COSCIENS Biopharma logo
$3.96 -0.19 (-4.58%)
Closing price 07/24/2025 04:00 PM Eastern
Extended Trading
$4.00 +0.04 (+1.01%)
As of 07/24/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About COSCIENS Biopharma Stock (NASDAQ:CSCI)

Key Stats

Today's Range
$3.89
$4.05
50-Day Range
$3.33
$4.33
52-Week Range
$1.96
$6.77
Volume
4,495 shs
Average Volume
4,953 shs
Market Capitalization
$12.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for COSCIENS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

CSCI Stock News Headlines

CSCI COSCIENS Biopharma Inc.
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

CSCI Stock Analysis - Frequently Asked Questions

COSCIENS Biopharma's stock was trading at $2.77 at the beginning of 2025. Since then, CSCI shares have increased by 43.0% and is now trading at $3.96.

COSCIENS Biopharma Inc. (NASDAQ:CSCI) released its earnings results on Tuesday, May, 13th. The company reported ($1.16) earnings per share (EPS) for the quarter. The firm earned $1.50 million during the quarter. COSCIENS Biopharma had a negative net margin of 194.50% and a negative trailing twelve-month return on equity of 101.01%.

Shares of CSCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that COSCIENS Biopharma investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Last Earnings
5/13/2025
Today
7/25/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CSCI
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.80)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.31 million
Net Margins
-194.50%
Pretax Margin
-189.00%
Return on Equity
-101.01%
Return on Assets
-43.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.88
Quick Ratio
2.54

Sales & Book Value

Annual Sales
$9.59 million
Price / Sales
1.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.49 per share
Price / Book
1.13

Miscellaneous

Outstanding Shares
3,150,000
Free Float
3,144,000
Market Cap
$12.47 million
Optionable
N/A
Beta
0.76
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CSCI) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners